| scholarly article | Q13442814 |
| P356 | DOI | 10.7860/JCDR/2012/5004.2701 |
| P953 | full work available online at | https://doi.org/10.7860/jcdr/2012/5004.2701 |
| https://europepmc.org/articles/PMC3576782 | ||
| https://europepmc.org/articles/PMC3576782?pdf=render | ||
| P932 | PMC publication ID | 3576782 |
| P698 | PubMed publication ID | 23449881 |
| P2093 | author name string | Mayur Kumar | |
| Gaurav Swami | |||
| Juhi Aggarwal | |||
| P2860 | cites work | Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 |
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Mortality by cause for eight regions of the world: Global Burden of Disease Study | Q29615121 | ||
| Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism | Q33853989 | ||
| Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. | Q33989292 | ||
| Probiotics and safety | Q34130960 | ||
| Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans | Q34152486 | ||
| Diabetes, hypertension, and cardiovascular disease: an update | Q34220291 | ||
| The Treatment of Hypertension in Adult Patients With Diabetes | Q34482322 | ||
| Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
| Probiotics as functional food in the treatment of diarrhea | Q34575535 | ||
| Clinical usefulness of probiotics in inflammatory bowel diseases | Q34605032 | ||
| Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats | Q34605811 | ||
| Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. | Q34655571 | ||
| Probiotic Lactobacilli for urogenital health in women | Q34805133 | ||
| Probiotics in allergy management | Q34860166 | ||
| Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding | Q37051841 | ||
| Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial | Q39109399 | ||
| Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut | Q39640631 | ||
| Effect of conjugated linoleic acid on body composition in mice | Q42798101 | ||
| Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. | Q43684750 | ||
| Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. | Q43816619 | ||
| Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health | Q43823298 | ||
| Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats | Q43850663 | ||
| Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats | Q46382050 | ||
| Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats | Q51486234 | ||
| Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study | Q51557409 | ||
| Effect of probiotic-fermented, genetically modified soy milk on hypercholesterolemia in hamsters | Q51757991 | ||
| Early differences in fecal microbiota composition in children may predict overweight | Q53219254 | ||
| Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet | Q73064986 | ||
| Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) | Q73540460 | ||
| Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice | Q73699742 | ||
| Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans | Q74585959 | ||
| Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice | Q79810116 | ||
| Probiotics and obesity | Q85008092 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lactobacillus | Q1061596 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 173-177 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Journal of clinical and diagnostic research JCDR | Q26842849 |
| P1476 | title | Probiotics and their Effects on Metabolic Diseases: An Update | |
| P478 | volume | 7 |
| Q36502458 | Construction of a Recombinant Leuconostoc mesenteroides CJNU 0147 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Factor |
| Q90149739 | Deciphering the microbiome shift during fermentation of medicinal plants |
| Q36606608 | Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes |
| Q46323567 | Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials |
| Q35587142 | Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota. |
| Q42343801 | Lactic acid bacterial infection, probiotics and gut microbiomes |
| Q27006800 | Physiology and its importance for reference intervals |
| Q38754711 | Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes |
| Q64910852 | Probiotics in Extraintestinal Diseases: Current Trends and New Directions. |
| Q49822123 | Specific synbiotics in early life protect against diet-induced obesity in adult mice. |
| Q34470609 | The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial |
| Q27014922 | The role of the gut microbiome in the pathogenesis and treatment of obesity |
Search more.